1st Quarter - Report

JENNINGS POLICY STRATEGIES for COALITION FOR A COMPETITIVE PHARMACEUTICAL MARKET

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.

LobbyistCovered position, as disclosed
CHRISTOPHER JENNINGS —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3200 (111th), H.R. 1427 (111th), H.R. 1548 (111th), H.R. 3495 (111th), S. 726 (111th)

Pharmacy PHA

Advocate for the creation of a regulatory pathway for generic biologic medications and policies that promotes innovation and competition and ensures affordability in the pharmaceutical marketplace, including but not limited to H.R. 1427, S. 726 and H.R. 1548, HR 3200, HR 3495.

LobbyistCovered position, as disclosed
CHRISTOPHER JENNINGS —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), S. 726 (111th), H.R. 3495 (111th), H.R. 3200 (111th), H.R. 1427 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.